1Tiede DJ, Nishimura RA, Gastineau DA, et al. Modern management of prosthetic valve anticoagulation. Mayo Clin Proc,1998,73(7) :665-680.
2Edmonds LH Jr, Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liason Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Sure, 1996.62(3) : 932-935.
3Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation, 1996, 94(9):2107-2112.
4Butchart EG, Payne N, I.i HH, et al. Better anticoagulation control improves survival after valve replacement. J Thorac Cardlovasc Surg, 2002,123(4):715-723.
5Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement : is an early start advantageous? Ann Thorac Surg, 2001, 72 (1) :44-48.
10Bussey HI. An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves [J ]. Heart Valve Dis,2004,13(3) :319 - 324.
